BacPROTAC-induced protein degradation as a new antibiotic concept
Open Access
- 17 February 2026
- journal article
- review article
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 51 (3) , 249-260
Abstract
No abstract availableKeywords
Funding Information
- Boehringer Ingelheim
This publication has 56 references indexed in Scilit:
- A generative deep learning approach to de novo antibiotic designCell, 2025
- Degradome analysis to identify direct protein substrates of small-molecule degradersCell Chemical Biology, 2024
- Clp-targeting BacPROTACs impair mycobacterial proteostasis and survivalCell, 2023
- BacPROTACs mediate targeted protein degradation in bacteriaCell, 2022
- Combinatorial degradomics: Precision tools to unveil proteolytic processes in biological systemsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2020
- Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological DiscoveryCell, 2020
- Synthesis of New Cyclomarin Derivatives and Their Biological Evaluation towards Mycobacterium Tuberculosis and Plasmodium FalciparumChemistry – A European Journal, 2019
- When barriers ignore the “rule-of-five”Advanced Drug Delivery Reviews, 2016
- Lassomycin, a Ribosomally Synthesized Cyclic Peptide, Kills Mycobacterium tuberculosis by Targeting the ATP-Dependent Protease ClpC1P1P2Chemistry & Biology, 2014
- The Natural Product Cyclomarin Kills Mycobacterium Tuberculosis by Targeting the ClpC1 Subunit of the Caseinolytic ProteaseAngewandte Chemie International Edition, 2011